Natixis Advisors, L.P. Grifols Sa Transaction History
Natixis Advisors, L.P.
- $68.5 Billion
- Q3 2025
A detailed history of Natixis Advisors, L.P. transactions in Grifols Sa stock. As of the latest transaction made, Natixis Advisors, L.P. holds 199,922 shares of GRFS stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
199,922
Previous 204,134
2.06%
Holding current value
$1.74 Million
Previous $1.85 Million
7.91%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...